Full Name
Abraham Shaked
Job Title
Professor of Suregry
Company/Institution/ Organization
University of Pennsylvania
Speaker Bio
Abraham Shaked MD, PhD
Liver Transplant Surgeon at Penn and CHOP
1982 M.D. Hebrew University, Israel
1989 Ph.D. City University of New York
1982-9 Resident Surgery, Mount Sinai Medical Center, NY
1990-1995 Assistant to Associate Professor of Surgery, UCLA
1995- present Eldridge L. Eliason Professor of Surgery, University of Pennsylvania and Children Hospital of Philadelphia
2006- 2023 Director of the Penn Transplant institute
Past President of the American Society of Transplant Surgeons
Research efforts have focused on advancing the fields of transplant genetics and xenotransplantation, with particular emphasis on understanding the molecular, immunologic, and metabolic determinants of graft function and long-term outcomes. This work integrates genomic and biomarker discovery approaches with translational models of organ support and replacement, including the study of genetically engineered porcine liver for clinical application. The program has been continuously supported by multiple National Institutes of Health grants over many years, reflecting sustained federal investment in both the fundamental biology and the clinical translation of these innovations.
Liver Transplant Surgeon at Penn and CHOP
1982 M.D. Hebrew University, Israel
1989 Ph.D. City University of New York
1982-9 Resident Surgery, Mount Sinai Medical Center, NY
1990-1995 Assistant to Associate Professor of Surgery, UCLA
1995- present Eldridge L. Eliason Professor of Surgery, University of Pennsylvania and Children Hospital of Philadelphia
2006- 2023 Director of the Penn Transplant institute
Past President of the American Society of Transplant Surgeons
Research efforts have focused on advancing the fields of transplant genetics and xenotransplantation, with particular emphasis on understanding the molecular, immunologic, and metabolic determinants of graft function and long-term outcomes. This work integrates genomic and biomarker discovery approaches with translational models of organ support and replacement, including the study of genetically engineered porcine liver for clinical application. The program has been continuously supported by multiple National Institutes of Health grants over many years, reflecting sustained federal investment in both the fundamental biology and the clinical translation of these innovations.
Speaking At
